NĀ HAʻAWINA HIHIA O KĒIA MANAWA
Pane Kupaianaha i ka Myeloma Multiple Refractory Ma hope o ka CAR-T Cell Therapy
Inoa: ʻO Mohamed H
Kāne/Wahine:Kāne
Makahiki:70
Lāhui: ʻAikupita
Hōʻike: ʻO ka myeloma lehulehu
ʻO ka Myeloma Nui (MM)-02
MaʻiKulanakauhale
Kāne/WahineWahine
Makahiki66 makahiki
Lāhui: Ikalia
ʻIkepili:Mīeloma lehulehu (MM)
ʻO ka Myeloma Nui (MM)-01
MaʻiʻAʻohe inoa
Kāne/WahineWahine
Makahiki25 makahiki
LāhuiʻAukekulelia
ʻIkepili:Mīeloma lehulehu (MM)
Ke Kaua o Wu: Ke ʻeha nei i ka myeloma lehulehu
Inoa: ʻAʻole i hāʻawi ʻia
Kāne/Wahine: Kāne
Makahiki: 73
Lāhui: ʻAʻole i hāʻawi ʻia
Hōʻike: ʻO ka Myeloma lehulehu me ka Extramedullary Plasmacytoma
Bjørn Simensen----Multiple Myeloma (IgG lambda) ISS-II
Inoa: ʻO Bjorn Simensen
Kāne/Wahine: Kāne
Makahiki: 67
Lāhui: Nolewai
Hōʻike: ʻO ka Myeloma lehulehu (IgG lambda) ISS-II
ʻO Cody Insley Campbell----Medical Myeloma
Inoa: ʻO Cody Insley Campbell
Kāne/Wahine: Kāne
Makahiki: ʻAʻole i kuhikuhi ʻia
Lāhui: Kanada
Hōʻike: ʻO ka Myeloma lehulehu
ʻO ka Myeloma lehulehu me ka Extramedullary Plasmacytoma
Inoa: ʻAʻole i hāʻawi ʻia
Kāne/Wahine: Kāne
Makahiki: 73
Lāhui: ʻAʻole i hāʻawi ʻia
Hōʻike: ʻO ka Myeloma lehulehu me ka Extramedullary Plasmacytoma
